Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
J Am Acad Dermatol ; 82(6): 1415-1421, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31541747

ABSTRACT

BACKGROUND: Chronic pruritus causes major morbidity in epidermolysis bullosa (EB). The substance P-neurokinin 1 receptor (SP-NK1) pathway is a promising target for treating EB-related pruritus. OBJECTIVE: To evaluate the safety and efficacy of the oral NK1 receptor antagonist serlopitant in treating moderate-severe pruritus in EB. METHODS: The study randomized 14 patients to serlopitant or placebo for 8 weeks, followed by a 4-week washout and optional open-label extension. The primary end point was change in itch as measured by the Numeric Rating Scale. Secondary end points were change in itch during dressing changes and wound size. RESULTS: We observed greater itch reduction with serlopitant, equivalent to a 0.64-point comparative reduction on the 11-point Numeric Rating Scale by week 8, although this failed to meet statistical significance (P = .11). More serlopitant patients achieved ≥3-point reduction compared with placebo (43% vs 14%, P = .35). In post hoc analysis excluding 1 patient with a concurrent seborrheic dermatitis flare, serlopitant achieved significantly greater median itch reduction from baseline by week 4 (-2 points vs 0, P = .01). We observed no statistically significant differences in secondary end points. Serlopitant was well-tolerated. LIMITATIONS: Small sample size due to disease rarity. CONCLUSION: The potential itch reduction with serlopitant observed in this trial will be pursued by a larger powered trial (NCT03836001).


Subject(s)
Neurokinin-1 Receptor Antagonists/therapeutic use , Pruritus/drug therapy , Adolescent , Adult , Double-Blind Method , Epidermolysis Bullosa/complications , Female , Humans , Male , Middle Aged , Pruritus/etiology , Young Adult
2.
Toxicological Research ; : 43-52, 2013.
Article in English | WPRIM (Western Pacific) | ID: wpr-118065

ABSTRACT

Zearalenone (ZEN) is a non-steroidal estrogenic mycotoxin produced by several species of Fusarium that are found in cereals and agricultural products. ZEN has been implicated in mycotoxicosis in farm animals and in humans. The toxic effects of ZEN are well known, but the ability of an alkaline Comet assay to assess ZEN-induced oxidative DNA damage in Chang liver cells has not been established. The first aim of this study was to evaluate the Comet assay for the determination of cytotoxicity and extent of DNA damage induced by ZEN toxin, and the second aim was to investigate the ability of N-acetylcysteine amide (NACA) to protect cells from ZEN-induced toxicity. In the Comet assay, DNA damage was assessed by quantifying the tail extent moment (TEM; arbitrary unit) and tail length (TL; arbitrary unit), which are used as indicators of DNA strand breaks in SCGE. The cytotoxic effects of ZEN in Chang liver cells were mediated by inhibition of cell proliferation and induction of oxidative DNA damage. Increasing the concentration of ZEN increased the extent of DNA damage. The extent of DNA migration, and percentage of cells with tails were significantly increased in a concentration-dependent manner following treatment with ZEN toxin (p < 0.05). Treatment with a low concentration of ZEN toxin (25 microM) induced a relatively low level of DNA damage, compared to treatment of cells with a high concentration of ZEN toxin (250 microM). Oxidative DNA damage appeared to be a key determinant of ZEN-induced toxicity in Chang liver cells. Significant reductions in cytolethality and oxidative DNA damage were observed when cells were pretreated with NACA prior to exposure to any concentration of ZEN. Our data suggest that ZEN induces DNA damage in Chang liver cells, and that the antioxidant activity of NACA may contribute to the reduction of ZEN-induced DNA damage and cytotoxicity via elimination of oxidative stress.


Subject(s)
Humans , Acetylcysteine , Animals, Domestic , Cell Proliferation , Edible Grain , Comet Assay , DNA , DNA Damage , Electrophoresis , Estrogens , Fusarium , Liver , Mycotoxicosis , Oxidative Stress , Zearalenone
3.
Toxicological Research ; : 61-67, 2013.
Article in English | WPRIM (Western Pacific) | ID: wpr-118063

ABSTRACT

Development of a therapy providing protection from, or reversing gentamicin-sulfate (GS)-induced oxidative stress and nephrotoxicity would be of great clinical significance. The present study was designed to investigate the protective effects of Houttuynia cordata Thunb. (HC) against gentamicin sulfate-induced renal damage in rats. Twenty-eight Sprague-Dawley rats were divided into 4 equal groups as follows: group 1, control; group 2, GS 100 mg/kg/d, intraperitoneal (i.p.) injection; group 3, GS 100 mg/kg/d, i.p. + HC 500 mg/kg/d, oral; and group 4, GS 100 mg/kg/d i.p. + HC 1000 mg/kg/d, oral administration). Treatments were administered once daily for 12 d. After 12 d, biochemical and histopathological analyses were conducted to evaluate oxidative stress and renal nephrotoxicity. Serum levels of creatinine, malondialdehyde (MDA), and blood urea nitrogen (BUN), together with renal levels of MDA, glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were quantified to evaluate antioxidant activity. Animals treated with GS alone showed a significant increase in serum levels of creatinine, BUN, and MDA, with decreased renal levels of GSH, SOD, and CAT. Treatment of rats with HC showed significant improvement in renal function, presumably as a result of decreased biochemical indices and oxidative stress parameters associated with GS-induced nephrotoxicity. Histopathological examination of the rat kidneys confirmed these observations. Therefore, the novel natural antioxidant HC may protect against GS-induced nephrotoxicity and oxidative stress in rats.


Subject(s)
Animals , Cats , Rats , Blood Urea Nitrogen , Catalase , Creatinine , Drug Combinations , Gentamicins , Glutathione , Glycerides , Houttuynia , Kidney , Malondialdehyde , Monoterpenes , Oxidative Stress , Rats, Sprague-Dawley , Superoxide Dismutase
4.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-83910

ABSTRACT

BACKGROUND: Elderly population in Japan was 14.5% of whole population in 1997, it is estimated 27.4% in 2025 and 32.3% in 2050. Average life span in 1995 was 76.8yrs for men, 82.5yrs for women Now Japan can be called by a society of advanced age, so there can be so many economic and welfare problems to be resolved. METHODS: Increasing of the advanced aged and the life span is calling for Japan to take a fundamental countermeasures for aging welfare policy. RESULTS: Aging welfare policy is changed from poor relief and selective one to general and universal one. For example, delivery system of welfare service is changed from one-way service supply system by administration to service utilization system by person with needs. CONCLUSION: The objects for service is focused not only at low income peoples, but also at all members of nation regardless of incomes. And medical health service is also focused not only at treatment of disease before, but also at councelling and care for improvement of health.


Subject(s)
Aged , Female , Humans , Male , Aging , Health Services , Japan
SELECTION OF CITATIONS
SEARCH DETAIL
...